Uncover key drivers, emerging technologies, and competitive movements shaping the cell therapy raw materials market from 2026–2035 with trusted insights from The Business Research Company
How is the Cell Therapy Raw Materials Market size predicted to change over the forecast window of 2026–2035?
The cell therapy raw materials market size has experienced significant expansion in recent years. This market is projected to rise from $5.07 billion in 2025 to $6.1 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 20.4%. Historically, this growth was propelled by the early-stage development of cell therapies, a dependence on animal-derived sera, the limited scalability of cell culture processes, expanding academic and clinical research in cell therapy, and increasing investment in regenerative medicine.
The cell therapy raw materials market is projected for substantial growth in the upcoming years, with its size anticipated to reach $12.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 20.2%. This expected growth during the forecast period is attributed to the commercialization of cell and gene therapies, a rising demand for CAR-T treatments, ongoing advancements in cell expansion and cryopreservation materials, increasing regulatory scrutiny on raw material quality, and the expansion of biopharmaceutical manufacturing capacity. Key trends for this period include a growing demand for high-quality and consistent cell culture media, increased adoption of serum-free and chemically defined raw materials, the expansion of CAR-T and gene therapy manufacturing pipelines, an increase in outsourcing to specialized raw material suppliers, and an enhanced focus on regulatory compliance and traceability.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27245&type=smp
Which Drivers Are Contributing To The Expansion Of The Cell Therapy Raw Materials Market?
The expanding application of regenerative medicine is anticipated to stimulate the growth of the cell therapy raw materials market in the foreseeable future. Regenerative medicine is a medical field dedicated to restoring or establishing normal physiological function by replacing, engineering, or regenerating human cells, tissues, or organs. The increase in regenerative medicine is attributed to the growing incidence of chronic and degenerative diseases, which in turn boosts the demand for therapies that repair or substitute damaged tissues rather than merely managing symptoms. Cell therapy raw materials are instrumental in progressing regenerative medicine by furnishing essential components, such as growth factors, cell culture media, enzymes, and scaffolds, which are necessary for cultivating, expanding, and maintaining therapeutic cells utilized to repair or regenerate compromised tissues and organs. For instance, in January 2025, the National Library of Medicine, a US-based biomedical library, reported that 32 new gene therapies, including genetically modified cell therapies, had been approved in 2024. Therefore, the expanding utilization of regenerative medicine is a primary driver for the cell therapy raw materials market’s growth.
What Segment Categories Are Covered In The Cell Therapy Raw Materials Market?
The cell therapy raw materials market covered in this report is segmented –
1) By Therapy Area: Stem Cell Based Raw Materials, Gene Therapy Raw Materials, CAR-T Cell Therapy Raw Materials
2) By Product Type: Media, Sera, Cell Culture Supplements, Antibodies, Reagents And Buffers, Other Product Types
3) By End User: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organization And Contract Manufacturing Organization, Other End Users
Subsegments:
1) By Stem Cell Based Raw Materials: Growth Factors, Cytokines, Cell Culture Media
2) By Gene Therapy Raw Materials: Transfection Reagents, Nucleotides And Enzymes, Cell Culture Media For Gene Modification
3) By Car-T Cell Therapy Raw Materials: T Cell Activation Reagents, Cell Expansion Media, Cryopreservation Agents
What Trends Are Expected To Impact The Competitive Landscape Of The Cell Therapy Raw Materials Market?
Leading companies within the cell therapy raw materials sector are prioritizing the creation of groundbreaking solutions, such as manufacturing practices that adhere to good manufacturing practice (GMP) standards. This focus aims to guarantee the safety, uniformity, and adherence to regulations for products throughout the entire cell therapy production cycle. Good manufacturing practice (GMP)-compliant manufacturing describes a structured approach designed to ensure that products are consistently made and managed according to quality benchmarks established by regulatory bodies, thereby mitigating risks in pharmaceutical and biotechnological production. As an illustration, in April 2025, Thermo Fisher Scientific Inc., an American life science and clinical research company based in the US, introduced a US advanced therapies collaboration center (ATxCC). This center was established to facilitate the advancement and market entry of cell and gene therapies. It boosts cell therapy development by offering comprehensive cGMP manufacturing assistance, cutting-edge technologies, and specialized process optimization. Furthermore, it promotes cooperation to tackle manufacturing challenges and speed up commercialization.
Which Major Industry Participants Are Leading The Cell Therapy Raw Materials Market Growth?
Major companies operating in the cell therapy raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Lonza Group AG, Sartorius Stedim Biotech SA, Bio-Techne Corporation, Stemcell Technologies Inc., Miltenyi Biotec GmbH, ACROBiosystems Co Ltd., CellGenix GmbH, Promocell GmbH, RoosterBio Inc., Akron Biotech LLC.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/cell-therapy-raw-materials-global-market-report
Which Region Is Expected To Experience The Fastest Growth In The Cell Therapy Raw Materials Market?
North America was the largest region in the cell therapy raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Cell Therapy Raw Materials Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27245&type=smp
Browse Through More Reports Similar to the Global Cell Therapy Raw Materials Market 2026, By The Business Research Company
Wooden Interior Door Market Report 2026
https://www.thebusinessresearchcompany.com/report/wooden-interior-door-global-market-report
Aluminum Doors And Windows Market 2026
https://www.thebusinessresearchcompany.com/report/aluminum-doors-and-windows-market
Aluminum Doors And Windows Market Report 2026
https://www.thebusinessresearchcompany.com/report/aluminum-doors-and-windows-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model